The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Moreadith Randall since 2025.
This trader's CIK number is 1301120.
At the time of last reporting, Moreadith Randall was the Chief Scientific Officer of Serina Therapeutics, Inc.. (stock ticker symbol SER).
Also see all insider trading activities at Serina Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SER | 0 | $0 | 106,174 | $650,834 | 106,174 | $6,367 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-25 | SER | Option Ex | 2,042 | .06 | 122 |
| 2025-08-26 | SER | Option Ex | 45,632 | .06 | 2,737 |
| 2025-08-25 | SER | Sale | 2,042 | 5.65 | 11,537 |
| 2025-08-26 | SER | Sale | 45,632 | 7.01 | 319,880 |
| 2025-08-20 | SER | Option Ex | 2,077 | .06 | 124 |
| 2025-08-18 | SER | Option Ex | 2,227 | .06 | 133 |
| 2025-08-20 | SER | Sale | 2,077 | 5.10 | 10,592 |
| 2025-08-18 | SER | Sale | 2,227 | 5.25 | 11,691 |
| 2025-08-12 | SER | Option Ex | 5,500 | .06 | 330 |
| 2025-08-12 | SER | Sale | 5,500 | 5.25 | 28,875 |
| 2025-08-04 | SER | Option Ex | 5,500 | .06 | 330 |
| 2025-08-04 | SER | Sale | 5,500 | 5.17 | 28,435 |
| 2025-07-29 | SER | Option Ex | 4,196 | .06 | 251 |
| 2025-07-29 | SER | Sale | 4,196 | 6.50 | 27,274 |
| 2025-07-28 | SER | Option Ex | 6,500 | .06 | 390 |
| 2025-07-28 | SER | Sale | 6,500 | 5.89 | 38,285 |
| 2025-07-21 | SER | Option Ex | 6,500 | .06 | 390 |
| 2025-07-21 | SER | Sale | 6,500 | 5.34 | 34,710 |
| 2025-07-14 | SER | Sale | 6,500 | 5.01 | 32,565 |
| 2025-07-14 | SER | Option Ex | 6,500 | .06 | 390 |
| 2025-07-14 | SER | Sale | 6,500 | 5.01 | 32,565 |
| 2025-07-14 | SER | Option Ex | 6,500 | .06 | 390 |
| 2025-07-07 | SER | Option Ex | 6,500 | .06 | 390 |
| 2025-07-07 | SER | Sale | 6,500 | 5.67 | 36,855 |
| 2025-06-30 | SER | Option Ex | 6,500 | .06 | 390 |
| 2025-06-30 | SER | Sale | 6,500 | 5.78 | 37,570 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moreadith Randall (Chief Scientific Officer of Serina Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.